PHARMACOECONOMIC BURDEN AND COST-REDUCTION IMPACT OF PHARMACIST-LED BRAND SUBSTITUTION IN HYPERTENSION MANAGEMENT: A CROSS-SECTIONAL STUDY FROM PAKISTAN. (2025). Frontier in Medical and Health Research, 3(8), 828-836. https://fmhr.net/index.php/fmhr/article/view/1422